0.2600
-0.0600
(-18.75%)
At close: January 31 at 5:09:27 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
52,562.4150
55,293.8050
48,552.1490
13,533.7470
Total Liabilities Net Minority Interest
3,717.8680
5,127.5490
4,651.8060
2,512.2790
Total Equity Gross Minority Interest
48,844.5470
50,166.2560
43,900.3430
11,021.4680
Total Capitalization
49,494.5470
51,366.2560
44,900.3430
11,331.4680
Common Stock Equity
48,844.5470
50,166.2560
43,900.3430
11,021.4680
Net Tangible Assets
48,843.6710
50,163.6130
43,899.0180
11,021.4680
Working Capital
772.7210
5,171.0360
31,153.4130
10,978.3730
Invested Capital
49,495.1330
51,370.2310
44,905.3530
11,332.9250
Tangible Book Value
48,843.6710
50,163.6130
43,899.0180
11,021.4680
Total Debt
650.5860
1,203.9750
1,005.0100
311.4570
Net Debt
--
1,160.8950
--
--
Share Issued
0.0350
0.0030
0.2480
0.0080
Ordinary Shares Number
0.0350
--
--
--
12/31/2020 - 4/21/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1RT.F Nuformix plc
0.0005
0.00%
ALVIO.PA Valerio Therapeutics Société anonyme
0.0780
+1.30%
ABTEC.OL Aqua Bio Technology ASA
3.2400
+3.18%
ALTME.PA TME Pharma N.V.
0.0702
+0.29%
NFX.L Nuformix plc
0.0700
-6.67%
BCLI Brainstorm Cell Therapeutics Inc.
1.8200
-6.19%
LGND Ligand Pharmaceuticals Incorporated
116.55
-1.76%
IVVD Invivyd, Inc.
0.3577
-8.28%
BTAI BioXcel Therapeutics, Inc.
0.3260
+0.96%
CDT Conduit Pharmaceuticals Inc.
2.4800
-2.75%